Healthpeak Properties, Inc.

🇺🇸New York Stock Exchange
Back to all articles
Healthpeak Properties, Inc. stock analysis DOC overview
Bullish +65

Healthpeak Properties Stock (US42226K1051): analyst upgrade and ex-dividend date put income REIT in - AD HOC NEWS

📈 BMO Capital raised Healthpeak's price target to $24 from $20 while reiterating an 'Outperform' rating.

💰 The stock is trading ex-dividend today with a monthly payout of $0.102 per share.

📊 Healthpeak offers a forward dividend yield of approximately 7.1% at current price levels.

🏢 Resources Management Corp CT ADV increased its stake by roughly 1,129% in Q4 to hold ~86,220 shares.

🌍 The company owns and manages healthcare discovery and delivery properties across the US.

📉 MarketBeat data shows a broader analyst consensus average target of $19.54.

📈 Recent performance figures indicate a gain of roughly 28% over a longer comparative period.

🏥 Portfolio includes medical office buildings, life science facilities, and senior care assets.

📅 The stock is listed on the NYSE under the ticker DOC with CUSIP US42226K1051.

Bullish Signals
  • BMO Capital upgraded the price target to $24, implying mid-teens percentage upside from the recent closing price of $20.69.
  • The company maintains a strong 'Outperform' rating despite a broader market consensus that leans towards a 'Hold'.
  • Resources Management Corp CT ADV demonstrated significant conviction by increasing its position by over 1,100% in Q4.
  • Healthpeak offers an attractive forward dividend yield of approximately 7.1% with monthly distribution frequency.
  • The portfolio focuses on long-term leases with hospital systems and physician groups, providing visibility on rental income.
Risk Factors
  • The broader analyst consensus average price target is $19.54, which is lower than BMO's new target of $24.
  • Healthcare REITs face exposure to sector-specific regulatory and reimbursement risks that could impact cash flows.
  • Yield calculations fluctuate with share price changes, meaning the 7.1% yield is not guaranteed to remain constant.
Full Analysis
Healthpeak Properties (DOC) is attracting attention from income-focused investors following an analyst upgrade and its ex-dividend date. BMO Capital raised its price target to $24 from $20 while maintaining an 'Outperform' rating, a move that stands out against the broader consensus average target of approximately $19.54 reported by MarketBeat. The company is trading ex-dividend for a monthly payout of $0.102 per share, offering a forward dividend yield of roughly 7.1%. Healthpeak operates as a fully integrated healthcare REIT with a portfolio focused on medical office buildings, life science facilities, and senior or post-acute care assets across the United States. Institutional activity also highlights growing interest, as Resources Management Corp CT ADV sharply increased its stake in the fourth quarter by approximately 1,129%, adding roughly 79,210 shares to its holdings. The stock recently closed near $20.69 on the NYSE, with analysts noting potential upside driven by demographic trends and demand for healthcare services.